Embarking on a new era in high-risk biochemical recurrent prostate cancer: redefining early systemic intervention.
- DOI
- 10.1016/j.pharmthera.2026.109104
- Published
- 2026 Aug 25
- Container
- Pharmacology & therapeutics
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.pharmthera.2026.109104,
title = {Embarking on a new era in high-risk biochemical recurrent prostate cancer: redefining early systemic intervention.},
author = {Izzi M and Lapucci A and Catalano M and Vascotto IA and Calandrelli C and Mancini S and Pratesi L and Mela MM and Rossi V and Pillozzi S and Koatale PC and Roberts R and Matthews D and Cerbone L and Perrella A and Santoni M and Antonuzzo L and Roviello G},
year = {2026},
journal = {Pharmacology \& therapeutics},
doi = {10.1016/j.pharmthera.2026.109104},
url = {https://doi.org/10.1016/j.pharmthera.2026.109104}
}RIS
TY - JOUR TI - Embarking on a new era in high-risk biochemical recurrent prostate cancer: redefining early systemic intervention. AU - Izzi M AU - Lapucci A AU - Catalano M AU - Vascotto IA AU - Calandrelli C AU - Mancini S AU - Pratesi L AU - Mela MM AU - Rossi V AU - Pillozzi S AU - Koatale PC AU - Roberts R AU - Matthews D AU - Cerbone L AU - Perrella A AU - Santoni M AU - Antonuzzo L AU - Roviello G PY - 2026 JO - Pharmacology & therapeutics DO - 10.1016/j.pharmthera.2026.109104 UR - https://doi.org/10.1016/j.pharmthera.2026.109104 ER -
APA
M, I., A, L., M, C., IA, V., C, C., S, M., L, P., MM, M., V, R., S, P., PC, K., R, R., D, M., L, C., A, P., M, S., L, A., & G, R. (2026). Embarking on a new era in high-risk biochemical recurrent prostate cancer: redefining early systemic intervention.. Pharmacology & therapeutics. https://doi.org/10.1016/j.pharmthera.2026.109104
Source records
- pubmed · retrieved 2026-09-26T01:25:32.267Z
- europe-pmc · retrieved 2026-09-26T01:25:32.278Z